The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Baker Charles A since 2006.
The trader's CIK number is 1225470.
At the time of the last reporting, Baker Charles A was the Director of Regeneron Pharmaceuticals, Inc.. (stock ticker symbol REGN).
Also see all insider trading activities at Regeneron Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | REGN | 0 | $0 | 2,000 | $900,000 | 2,000 | $37,220 |
| 2016 | REGN | 0 | $0 | 3,000 | $1,177,446 | 3,000 | $55,830 |
| 2015 | REGN | 0 | $0 | 10,000 | $5,024,660 | 10,000 | $186,100 |
| 2014 | REGN | 0 | $0 | 15,000 | $4,601,595 | 15,000 | $357,600 |
| 2013 | REGN | 0 | $0 | 30,000 | $8,503,065 | 30,000 | $532,350 |
| 2012 | REGN | 0 | $0 | 45,000 | $6,726,990 | 45,000 | $644,699 |
| 2011 | REGN | 0 | $0 | 11,000 | $622,963 | 15,000 | $432,150 |
| 2010 | REGN | 0 | $0 | 0 | $0 | 5,000 | $127,150 |
| 2009 | REGN | 0 | $0 | 10,000 | $181,600 | 10,000 | $76,600 |
| 2008 | REGN | 0 | $0 | 10,000 | $188,460 | 10,000 | $79,070 |
| 2006 | REGN | 0 | $0 | 10,000 | $153,520 | 10,000 | $120,000 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | PGNX | 0 | $0 | 2,500 | $75,050 | 2,500 | $48,750 |
1. Regeneron Pharmaceuticals, Inc. (REGN)
2. Progenics Pharmaceuticals Inc (PGNX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-29 | REGN | Option Ex | 2,000 | 18.61 | 37,220 |
| 2017-09-29 | REGN | Sale | 2,000 | 450.00 | 900,000 |
| 2016-12-12 | REGN | Option Ex | 3,000 | 18.61 | 55,830 |
| 2016-12-12 | REGN | Sale | 3,000 | 392.48 | 1,177,446 |
| 2015-09-17 | REGN | Option Ex | 5,000 | 18.61 | 93,050 |
| 2015-09-17 | REGN | Sale | 5,000 | 550.00 | 2,750,000 |
| 2015-03-25 | REGN | Option Ex | 5,000 | 18.61 | 93,050 |
| 2015-03-25 | REGN | Sale | 5,000 | 454.93 | 2,274,660 |
| 2014-03-24 | REGN | Sale | 15,000 | 306.77 | 4,601,595 |
| 2014-03-24 | REGN | Option Ex | 15,000 | 23.84 | 357,600 |
| 2013-09-30 | REGN | Option Ex | 15,000 | 19.69 | 295,350 |
| 2013-09-30 | REGN | Sale | 15,000 | 313.33 | 4,699,920 |
| 2013-06-10 | REGN | Sale | 15,000 | 253.54 | 3,803,145 |
| 2013-06-10 | REGN | Option Ex | 15,000 | 15.80 | 237,000 |
| 2012-11-26 | REGN | Option Ex | 15,000 | 9.17 | 137,550 |
| 2012-11-26 | REGN | Sale | 15,000 | 173.47 | 2,601,990 |
| 2012-09-06 | REGN | Sale | 13,714 | 150.00 | 2,057,100 |
| 2012-09-05 | REGN | Option Ex | 1,286 | 15.01 | 19,302 |
| 2012-09-06 | REGN | Option Ex | 13,714 | 15.01 | 205,847 |
| 2012-09-05 | REGN | Sale | 1,286 | 150.00 | 192,900 |
| 2012-04-17 | REGN | Option Ex | 2,090 | 18.80 | 39,292 |
| 2012-04-17 | REGN | Sale | 2,090 | 125.00 | 261,250 |
| 2012-04-19 | REGN | Option Ex | 12,910 | 18.80 | 242,708 |
| 2012-04-19 | REGN | Sale | 12,910 | 125.00 | 1,613,750 |
| 2011-08-10 | REGN | Option Ex | 4,000 | 28.81 | 115,240 |
| 2011-07-01 | REGN | Option Ex | 11,000 | 28.81 | 316,910 |
| 2011-07-01 | REGN | Sale | 11,000 | 56.63 | 622,963 |
| 2010-06-02 | REGN | Option Ex | 5,000 | 25.43 | 127,150 |
| 2009-02-20 | REGN | Option Ex | 10,000 | 7.66 | 76,600 |
| 2009-02-20 | REGN | Sale | 10,000 | 18.16 | 181,600 |
| 2008-02-15 | REGN | Option Ex | 10,000 | 7.91 | 79,070 |
| 2008-02-15 | REGN | Sale | 10,000 | 18.85 | 188,460 |
| 2006-02-01 | REGN | Option Ex | 10,000 | 12.00 | 120,000 |
| 2006-02-01 | REGN | Sale | 10,000 | 15.35 | 153,520 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-01-29 | PGNX | Option Ex | 2,500 | 19.50 | 48,750 |
| 2007-01-29 | PGNX | Sale | 2,500 | 30.02 | 75,050 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Charles A (Director of Regeneron Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.